50+ years of scientific excellence
Five decades of asking, ‘What if we tried this?’ A legacy built on scientific curiosity and the courage to push boundaries.
Where Breakthroughs Become Therapies
We bring clinical visions to life.
Scientifically. Globally. Seamlessly.
Defining what drives us
Driven by science. Delivered with purpose.
Specialty lab solutions, globally delivered:
Customized and scientifically driven to accelerate your drug program and development of therapeutics.
Specialty lab solutions that scale with your study
Oncology breakthroughs, emerging disease research, complex therapeutics development – we’re the lab partner with the range and scale to support your most important work.
Specialty lab testing
Cerba Research has an extensive history providing specialty lab and biomarker services. It’s in our DNA. Benefit from our customized service to obtain innovative, flexible solutions grounded in scientific expertise.
Centralized lab management
Leverage our global logistical and laboratory network, covering five continents. Cerba Research’s agile, customer-centric approach helps support the management of your clinical trials.
Therapeutic areas
With our unparalleled scientific expertise, our fast-expanding portfolio of therapeutic areas includes oncology, metabolic diseases, inflammation and immunology, infectious diseases and vaccines, autoimmune diseases, and rare diseases.
Why Cerba Research?
Integrated specialty and central lab workflow
When specialty expertise meets central lab scale, breakthroughs happen faster. One seamless workflow from the most complex assays to global trial coordination.
Global reach, local execution
Think global, act local. Our 1000+ laboratory network spans five continents, but every sample gets the personal attention it deserves.
Harmonized lab platforms
One global standard of excellence – from Stockholm to São Paulo. Consistent quality, wherever your trial takes you.
Our track record of results
42
laboratories globally
1,400+
clinical trials since 2018
>300
studies ongoing
30
publications per year
Specialized services to solve complex challenges
Every breakthrough therapy starts with the right assay, the right expertise, and the right approach.
Biomarkers
Discover our experience in the field of circulatory biomarkers. As your global partner for integrated clinical trial laboratory and diagnostic solutions, our goal at Cerba Research is to generate early scientific insights that optimize your protocol.
Immunoassays
You can rely on Cerba Research to outsource your research questions, including efficacy, safety, passive immunization, immunogenicity, pharmacokinetics, pathogenicity, antiviral therapy, antiviral prophylaxis, drug delivery, resistance mutants, and more.
Genomics
Leverage Cerba Research’s three-decade-plus experience in genomic sequencing to support your research.
Flow cytometry
Connect with our scientific team to learn how FCM can enhance your research and help you develop the panels you need.
Driving innovation across therapeutic areas
Tailored lab solutions turn scientific potential into patient impact with precision and speed, from oncology breakthroughs to rare and infectious diseases.
Oncology
Immuno-oncology and personalized medicine have sparked a revolution in cancer research, but working with global patient populations brings complex challenges.
Cerba Research shapes and advances your complex trials by leveraging industry-leading labs, patient databases, and scientific experts spanning five continents.
Because when it comes to cancer, every breakthrough matters. We don’t compromise.
Anti–infectives and vaccines
We provide world-class operational expertise, logistical infrastructure, and the scientific rigor needed to effectively characterize, research, and treat infectious diseases as they emerge.
We deploy an expert global team with the experience, knowledge, and cutting-edge technologies to accelerate clinical trials, reducing time to treatment. Empowered by our people, science, and technology.
Cell and gene therapy
We facilitate state-of-the-art technology, subject matter expertise, and specialized logistics and operations to accelerate cell and gene therapy development. Additionally, we ensure global distribution of sample kits, providing easy access worldwide.
Our specialized pick-up and transport services maintain the integrity of samples by utilizing dry ice and ensuring global coverage.
We’re not just running your trials. Together, we’re writing the next chapter of human health.
Inflammation and immunology
We advance inflammation and immunology research with specialized assays, immune cell profiling, and biomarker-driven insights supported by expert scientific teams.
Our global sample handling capabilities, kit distribution, and tailored logistics preserve integrity and accelerate study timelines.
More than delivering data, we help you decode immune-driven disease and move transformative therapies closer to patients.
Committed to advancing science responsibly
Explore how our global laboratory network integrates ethical practices, environmental stewardship, and community impact into every aspect of our work.
Discover the standards that guide us as we help shape a healthier, more sustainable future for patients – and for the planet.
Behind the scenes of the breakthroughs
Our scientists don’t just run assays. They solve puzzles.
Each whitepaper, case study, and research insight comes from real trials, real challenges, and real breakthroughs. This is where curiosity meets clinical impact. Explore the latest scientific publications, whitepapers, and case studies.
Welcome to Insight to Impact
Explore how Cerba Research powers clinical trials.
Our global team shares insights across all areas of clinical trial development.
Blog
Flow Matters: Illuminating Immune Responses in Virology and Vaccine Testing
Welcome to another edition of the Flow Matters blog. We’re diving into how flow cytometry is transforming virology and vaccine research and how new technological advances are giving researchers an unprecedented view of the immune system in action.
Blog
Flow Matters: The Role of Flow Cytometry in CAR-T Therapy Clinical Trials
Welcome back! In our last post, we covered some key background on what flow cytometry is and a general perspective on how to best utilize it within a clinical trial setting. In this post, we’re going to focus on a specific clinical application where flow cytometry is having a big impact: immunotherapy, in particular adoptive cell therapies like CAR-T.
Blog
Overcoming the Challenges of ADC Trials in Breast and Ovarian Cancer Treatment
Antibody-drug conjugates (ADCs) are becoming an exciting part of the treatment landscape for breast and ovarian cancer patients. Recent studies have shown particular success in ADC designs targeting HER2, TROP2, FRα, and NaPi2b to precision-deliver cytotoxic drugs directly to the tumor cells by exploiting the overexpression of these antigens on cancer cells compared to healthy tissue1,2.
